SlideShare a Scribd company logo
1 of 37
Insuficiencia
suprarrenal
Hospital General “Dr. Nicolás San Juan”
Servicio de Medicina Interna
Daniel Rebolledo García
R3 Medicina Interna
Diciembre 2018
Toluca, México
• Descrita por Thomas Addison en 1855.
(Debilidad, fatiga, anorexia, hipotensión ortostatica,
ingesta de sal).
• La causa mas frecuente en los casos descritos fue
la tuberculosis (siglo XIX).
Curr Opin Endocrinol Diabetes Obes. 2010 June ; 17(3): 217-223
Definición
• Es la falla de producción de todas las hormonas de la corteza suprarrenal.
• La causa más frecuente en países desarrollados es la autoinmune.
• Puede ocurrir de forma aislada, con otros cuadros autoinmunes (síndrome
poliglandular tipo 1 y 2).
• Mutaciones ligadas al gen AIRE.
• HLA genotipo DR3/4-DQB1*0302 (diabetes mellitus tipo 1).
• Adrenoleucodistrofia ligada al X.
Epidemiología
• Addison’s disease has a prevalence of 93-140 per million people and an
annual incidence of 4.7-6.2 per million people in Western populations.
• A survey of patients with Addison’s disease found that 60% had seen two or
more clinicians before the diagnosis of Addison’s disease was ever
considered.
• An observational study of children with Addison’s disease found that a delay in
diagnosis occurred in about a third of the cases, in whom the median duration
between the onset of first symptoms and the correct diagnosis was two years.
• Before the availability of synthetic glucocorticoid replacement therapy, the
disease resulted in a 2-year mortality above 80% and the death of all patients
within 5 years of diagnosis.
Lancet Diabetes Endocrinol 2014
Am Fam Physician. 2014;89(7):563-568
Lancet Diabetes Endocrinol 2014
Lancet Diabetes Endocrinol 2014
BMJ 2009;339:b2385
Am Fam Physician. 2014;89(7):563-568
Am Fam Physician. 2014;89(7):563-568
Am Fam Physician. 2014;89(7):563-568
Lancet Diabetes Endocrinol 2014
The American Journal of Medicine (2016) 129, 339.e1-339.e9
The American Journal of Medicine (2016) 129, 339.e1-339.e9
The American Journal of Medicine (2016) 129, 339.e1-339.e9
Manejo en urgencias…
• In patients in adrenal crisis after hospital admission, if acute adrenal
insufficiency is clinically suspected.
• Hydrocortisone should be given without delay (100 mg bolus injection,
followed by 200 mg per 24 h either as a continuous infusion or 50 mg every 6
h).
• Along with intravenous fluid resuscitation.
• Intravenous fluid resuscitation with isotonic sodium chloride 0.9% will correct
the hypovolemia and hyponatremia, while intravenous dextrose may also be
required to correct hypoglycemia.
• One liter of saline 0.9% should be given over the first hour, and further
replacement fluids should be guided by frequent hemodynamic monitoring
and measurement of serum electrolytes.
• Cortisol replacement can induce water diuresis and suppress antidiuretic
hormone (in secondary adrenal insufficiency), which together with sodium
replacement can lead to rapid correction of hyponatremia, and osmotic
demyelination syndrome.
• In the hospital, hydrocortisone can be given intravenously or intramuscularly
100 mg as a bolus, followed by 100-300 mg per day for another 2 to 3 days,
either as boluses every 6 hours or as continuous infusion until full recovery.
• At hydrocortisone doses of >50 mg/day, there is sufficient action at the
mineralocorticoid receptor, and it is generally accepted that additional
mineralocorticoid therapy is not required.
The American Journal of Medicine (2016) 129, 339.e1-339.e9
The American Journal of Medicine (2016) 129, 339.e1-339.e9
• Daily physiological production of cortisol is about 5–6 mg/m2 body surface
area.
• Recommended hydrocortisone doses are 15–25 mg, usually given in two to
three doses per day, with 50–66% given in the morning on awakening.
• If given two times a day, the second dose is usually given 6–8 h after the
morning dose.
• If given three times per day, the second dose is given 4–6 h after the early
morning dose and the third dose 4–6 h after this.
• A global survey of more than 1000 patients, mostly with primary adrenal
insufficiency.
• Hydrocortisone was the most common treatment (75%),
• Prednisone or prednisolone (11%),
• Cortisone (6%), and dexamethasone (4%).
• Cortisone
(1 mg hydrocortisone= 1.6 mg cortisone acetate)
• Prednisone
• (1.0 mg hydrocortisone=0.25 mg prednisone) need intrahepatic activation to
cortisol and prednisolone (1.0 mg hydrocortisone=0.2 mg prednisolone),
respectively, by 11β-hydroxy steroid dehydrogenase type 1, which might lead
to a higher pharmacokinetic variability compared with hydrocortisone.
Am Fam Physician. 2014;89(7):563-568
• Gracias!!!!

More Related Content

What's hot

Case presentation on Cerebrovascular accident (Stroke)
Case presentation on Cerebrovascular accident (Stroke)Case presentation on Cerebrovascular accident (Stroke)
Case presentation on Cerebrovascular accident (Stroke)HAMMADKC
 
Evidence based Management Preeclampsia / eclampsia
Evidence based Management Preeclampsia / eclampsiaEvidence based Management Preeclampsia / eclampsia
Evidence based Management Preeclampsia / eclampsiapogisurabaya
 
TDF associated Fanconi syndrome
TDF associated Fanconi syndromeTDF associated Fanconi syndrome
TDF associated Fanconi syndromeMing Chia Lee
 
Case presentation2
Case presentation2Case presentation2
Case presentation2FarragBahbah
 
4-1. Steroid-sensitive nephrotic syndrome. Francesco Emma (eng)
4-1. Steroid-sensitive nephrotic syndrome. Francesco Emma (eng)4-1. Steroid-sensitive nephrotic syndrome. Francesco Emma (eng)
4-1. Steroid-sensitive nephrotic syndrome. Francesco Emma (eng)KidneyOrgRu
 
Endocrine changes in critical care
Endocrine changes in critical careEndocrine changes in critical care
Endocrine changes in critical careSteve Mathieu
 
Hypertensive disorders of pregnancy and future maternal cardiovascular
Hypertensive disorders of pregnancy and future maternal cardiovascularHypertensive disorders of pregnancy and future maternal cardiovascular
Hypertensive disorders of pregnancy and future maternal cardiovascularDIPAK PATADE
 
MANAGING APLA - AN EVIDENCE BASED PRACTICAL APPROACH BY DR SHASHWAT JANI
MANAGING APLA - AN EVIDENCE BASED PRACTICAL APPROACH BY DR SHASHWAT JANIMANAGING APLA - AN EVIDENCE BASED PRACTICAL APPROACH BY DR SHASHWAT JANI
MANAGING APLA - AN EVIDENCE BASED PRACTICAL APPROACH BY DR SHASHWAT JANIDR SHASHWAT JANI
 
Ip5 Medical Case Study
Ip5 Medical Case StudyIp5 Medical Case Study
Ip5 Medical Case StudyMichelle Stahl
 
Crisis hiperglicemicas
Crisis hiperglicemicasCrisis hiperglicemicas
Crisis hiperglicemicasFRANCO MIO
 
A case study on hypertension
A case study on hypertensionA case study on hypertension
A case study on hypertensionDrMaheshGurajapu
 

What's hot (20)

A Case of NASH with HYPOTHYROIDISM
A Case of NASH with HYPOTHYROIDISMA Case of NASH with HYPOTHYROIDISM
A Case of NASH with HYPOTHYROIDISM
 
Case presentation on Cerebrovascular accident (Stroke)
Case presentation on Cerebrovascular accident (Stroke)Case presentation on Cerebrovascular accident (Stroke)
Case presentation on Cerebrovascular accident (Stroke)
 
Evidence based Management Preeclampsia / eclampsia
Evidence based Management Preeclampsia / eclampsiaEvidence based Management Preeclampsia / eclampsia
Evidence based Management Preeclampsia / eclampsia
 
Lupus nephritis update Ahmed Yehia
Lupus nephritis update Ahmed YehiaLupus nephritis update Ahmed Yehia
Lupus nephritis update Ahmed Yehia
 
A Case of ANCA Vasculitis
A Case of ANCA VasculitisA Case of ANCA Vasculitis
A Case of ANCA Vasculitis
 
Autoimmune endocrinopathies (Khaled el Hadidy)
Autoimmune endocrinopathies (Khaled el Hadidy)Autoimmune endocrinopathies (Khaled el Hadidy)
Autoimmune endocrinopathies (Khaled el Hadidy)
 
TDF associated Fanconi syndrome
TDF associated Fanconi syndromeTDF associated Fanconi syndrome
TDF associated Fanconi syndrome
 
Case presentation2
Case presentation2Case presentation2
Case presentation2
 
4-1. Steroid-sensitive nephrotic syndrome. Francesco Emma (eng)
4-1. Steroid-sensitive nephrotic syndrome. Francesco Emma (eng)4-1. Steroid-sensitive nephrotic syndrome. Francesco Emma (eng)
4-1. Steroid-sensitive nephrotic syndrome. Francesco Emma (eng)
 
Endocrine changes in critical care
Endocrine changes in critical careEndocrine changes in critical care
Endocrine changes in critical care
 
Hypertensive disorders of pregnancy and future maternal cardiovascular
Hypertensive disorders of pregnancy and future maternal cardiovascularHypertensive disorders of pregnancy and future maternal cardiovascular
Hypertensive disorders of pregnancy and future maternal cardiovascular
 
Gn master class
Gn master classGn master class
Gn master class
 
Autoimmune liver diseases
Autoimmune liver diseasesAutoimmune liver diseases
Autoimmune liver diseases
 
Nac
NacNac
Nac
 
MANAGING APLA - AN EVIDENCE BASED PRACTICAL APPROACH BY DR SHASHWAT JANI
MANAGING APLA - AN EVIDENCE BASED PRACTICAL APPROACH BY DR SHASHWAT JANIMANAGING APLA - AN EVIDENCE BASED PRACTICAL APPROACH BY DR SHASHWAT JANI
MANAGING APLA - AN EVIDENCE BASED PRACTICAL APPROACH BY DR SHASHWAT JANI
 
Preeclampsia 2010
Preeclampsia 2010Preeclampsia 2010
Preeclampsia 2010
 
Ip5 Medical Case Study
Ip5 Medical Case StudyIp5 Medical Case Study
Ip5 Medical Case Study
 
Crisis hiperglicemicas
Crisis hiperglicemicasCrisis hiperglicemicas
Crisis hiperglicemicas
 
Parkinson's Disease
Parkinson's Disease Parkinson's Disease
Parkinson's Disease
 
A case study on hypertension
A case study on hypertensionA case study on hypertension
A case study on hypertension
 

Similar to Insuficiencia suprarrenal 2018

Gout 2017 by Prof. Professor Sukhbir Uppal Consultant in Medicine/Rheumatolog...
Gout 2017 by Prof. Professor Sukhbir Uppal Consultant in Medicine/Rheumatolog...Gout 2017 by Prof. Professor Sukhbir Uppal Consultant in Medicine/Rheumatolog...
Gout 2017 by Prof. Professor Sukhbir Uppal Consultant in Medicine/Rheumatolog...University Hospital Sharjah
 
Diabetes mellitus and periodontitis
Diabetes mellitus and periodontitisDiabetes mellitus and periodontitis
Diabetes mellitus and periodontitisDr. Shweta Sarate
 
Autoimmune polyendocrine syndromes
Autoimmune polyendocrine syndromes Autoimmune polyendocrine syndromes
Autoimmune polyendocrine syndromes Tarun Prudvi Betha
 
Diabetes reversal Programme
 Diabetes reversal Programme  Diabetes reversal Programme
Diabetes reversal Programme paawan wadhawan
 
Cardiovascular and metabolic side effects of antipsychotics
Cardiovascular and metabolic side effects of antipsychoticsCardiovascular and metabolic side effects of antipsychotics
Cardiovascular and metabolic side effects of antipsychoticsPawan Sharma
 
Diabetes presentation 1 complete one
Diabetes presentation 1 complete oneDiabetes presentation 1 complete one
Diabetes presentation 1 complete oneLee-Ann Kara
 
Dental Implant 1 /certified fixed orthodontic courses by Indian dental academy
Dental Implant 1 /certified fixed orthodontic courses by Indian dental academy Dental Implant 1 /certified fixed orthodontic courses by Indian dental academy
Dental Implant 1 /certified fixed orthodontic courses by Indian dental academy Indian dental academy
 
Screening Models for Anti-Diabetic Drugs.
Screening Models for Anti-Diabetic Drugs.Screening Models for Anti-Diabetic Drugs.
Screening Models for Anti-Diabetic Drugs.Nisar Ali
 
Kidney transplantation power point
Kidney transplantation power pointKidney transplantation power point
Kidney transplantation power pointJOSEPHTALAT
 
Corticosteroids 170125054210
Corticosteroids 170125054210Corticosteroids 170125054210
Corticosteroids 170125054210yugalkishordubey
 
lifestyle disorders:diabetes
lifestyle disorders:diabeteslifestyle disorders:diabetes
lifestyle disorders:diabetesLee-Ann Kara
 
Organ donation in India
Organ donation in IndiaOrgan donation in India
Organ donation in IndiaAjai Sasidhar
 
Akt induced hepatitis dr.sunil
Akt induced hepatitis dr.sunilAkt induced hepatitis dr.sunil
Akt induced hepatitis dr.sunilSunil Pawar
 

Similar to Insuficiencia suprarrenal 2018 (20)

Gout 2017 by Prof. Professor Sukhbir Uppal Consultant in Medicine/Rheumatolog...
Gout 2017 by Prof. Professor Sukhbir Uppal Consultant in Medicine/Rheumatolog...Gout 2017 by Prof. Professor Sukhbir Uppal Consultant in Medicine/Rheumatolog...
Gout 2017 by Prof. Professor Sukhbir Uppal Consultant in Medicine/Rheumatolog...
 
Diabetes mellitus and periodontitis
Diabetes mellitus and periodontitisDiabetes mellitus and periodontitis
Diabetes mellitus and periodontitis
 
Presentation nsaids ams
Presentation nsaids amsPresentation nsaids ams
Presentation nsaids ams
 
Autoimmune polyendocrine syndromes
Autoimmune polyendocrine syndromes Autoimmune polyendocrine syndromes
Autoimmune polyendocrine syndromes
 
Diabetes reversal Programme
 Diabetes reversal Programme  Diabetes reversal Programme
Diabetes reversal Programme
 
Cardiovascular and metabolic side effects of antipsychotics
Cardiovascular and metabolic side effects of antipsychoticsCardiovascular and metabolic side effects of antipsychotics
Cardiovascular and metabolic side effects of antipsychotics
 
Kidney health
Kidney healthKidney health
Kidney health
 
Kidney health
Kidney health Kidney health
Kidney health
 
Diabetes presentation 1 complete one
Diabetes presentation 1 complete oneDiabetes presentation 1 complete one
Diabetes presentation 1 complete one
 
Latest in Lupus
Latest in LupusLatest in Lupus
Latest in Lupus
 
Dental Implant 1 /certified fixed orthodontic courses by Indian dental academy
Dental Implant 1 /certified fixed orthodontic courses by Indian dental academy Dental Implant 1 /certified fixed orthodontic courses by Indian dental academy
Dental Implant 1 /certified fixed orthodontic courses by Indian dental academy
 
Screening Models for Anti-Diabetic Drugs.
Screening Models for Anti-Diabetic Drugs.Screening Models for Anti-Diabetic Drugs.
Screening Models for Anti-Diabetic Drugs.
 
Kidney transplantation power point
Kidney transplantation power pointKidney transplantation power point
Kidney transplantation power point
 
Corticosteroids 170125054210
Corticosteroids 170125054210Corticosteroids 170125054210
Corticosteroids 170125054210
 
lifestyle disorders:diabetes
lifestyle disorders:diabeteslifestyle disorders:diabetes
lifestyle disorders:diabetes
 
Antituberculosis Adverse Drug Reactions
Antituberculosis Adverse Drug Reactions Antituberculosis Adverse Drug Reactions
Antituberculosis Adverse Drug Reactions
 
pemicu
pemicupemicu
pemicu
 
Organ donation in India
Organ donation in IndiaOrgan donation in India
Organ donation in India
 
Diabetes
DiabetesDiabetes
Diabetes
 
Akt induced hepatitis dr.sunil
Akt induced hepatitis dr.sunilAkt induced hepatitis dr.sunil
Akt induced hepatitis dr.sunil
 

Recently uploaded

Paris 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityParis 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityGeoBlogs
 
Interactive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communicationInteractive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communicationnomboosow
 
Concept of Vouching. B.Com(Hons) /B.Compdf
Concept of Vouching. B.Com(Hons) /B.CompdfConcept of Vouching. B.Com(Hons) /B.Compdf
Concept of Vouching. B.Com(Hons) /B.CompdfUmakantAnnand
 
Accessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactAccessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactdawncurless
 
Call Girls in Dwarka Mor Delhi Contact Us 9654467111
Call Girls in Dwarka Mor Delhi Contact Us 9654467111Call Girls in Dwarka Mor Delhi Contact Us 9654467111
Call Girls in Dwarka Mor Delhi Contact Us 9654467111Sapana Sha
 
How to Configure Email Server in Odoo 17
How to Configure Email Server in Odoo 17How to Configure Email Server in Odoo 17
How to Configure Email Server in Odoo 17Celine George
 
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptx
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptxContemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptx
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptxRoyAbrique
 
Mastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory InspectionMastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory InspectionSafetyChain Software
 
Introduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxIntroduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxpboyjonauth
 
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdfEnzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdfSumit Tiwari
 
The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13Steve Thomason
 
Alper Gobel In Media Res Media Component
Alper Gobel In Media Res Media ComponentAlper Gobel In Media Res Media Component
Alper Gobel In Media Res Media ComponentInMediaRes1
 
Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)eniolaolutunde
 
MENTAL STATUS EXAMINATION format.docx
MENTAL     STATUS EXAMINATION format.docxMENTAL     STATUS EXAMINATION format.docx
MENTAL STATUS EXAMINATION format.docxPoojaSen20
 
mini mental status format.docx
mini    mental       status     format.docxmini    mental       status     format.docx
mini mental status format.docxPoojaSen20
 
Organic Name Reactions for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions  for the students and aspirants of Chemistry12th.pptxOrganic Name Reactions  for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions for the students and aspirants of Chemistry12th.pptxVS Mahajan Coaching Centre
 

Recently uploaded (20)

Paris 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityParis 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activity
 
Interactive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communicationInteractive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communication
 
Concept of Vouching. B.Com(Hons) /B.Compdf
Concept of Vouching. B.Com(Hons) /B.CompdfConcept of Vouching. B.Com(Hons) /B.Compdf
Concept of Vouching. B.Com(Hons) /B.Compdf
 
Accessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactAccessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impact
 
Call Girls in Dwarka Mor Delhi Contact Us 9654467111
Call Girls in Dwarka Mor Delhi Contact Us 9654467111Call Girls in Dwarka Mor Delhi Contact Us 9654467111
Call Girls in Dwarka Mor Delhi Contact Us 9654467111
 
9953330565 Low Rate Call Girls In Rohini Delhi NCR
9953330565 Low Rate Call Girls In Rohini  Delhi NCR9953330565 Low Rate Call Girls In Rohini  Delhi NCR
9953330565 Low Rate Call Girls In Rohini Delhi NCR
 
Model Call Girl in Bikash Puri Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Bikash Puri  Delhi reach out to us at 🔝9953056974🔝Model Call Girl in Bikash Puri  Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Bikash Puri Delhi reach out to us at 🔝9953056974🔝
 
How to Configure Email Server in Odoo 17
How to Configure Email Server in Odoo 17How to Configure Email Server in Odoo 17
How to Configure Email Server in Odoo 17
 
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptx
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptxContemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptx
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptx
 
Mastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory InspectionMastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory Inspection
 
Introduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxIntroduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptx
 
Código Creativo y Arte de Software | Unidad 1
Código Creativo y Arte de Software | Unidad 1Código Creativo y Arte de Software | Unidad 1
Código Creativo y Arte de Software | Unidad 1
 
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdfEnzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
 
The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13
 
Alper Gobel In Media Res Media Component
Alper Gobel In Media Res Media ComponentAlper Gobel In Media Res Media Component
Alper Gobel In Media Res Media Component
 
Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)
 
MENTAL STATUS EXAMINATION format.docx
MENTAL     STATUS EXAMINATION format.docxMENTAL     STATUS EXAMINATION format.docx
MENTAL STATUS EXAMINATION format.docx
 
mini mental status format.docx
mini    mental       status     format.docxmini    mental       status     format.docx
mini mental status format.docx
 
Organic Name Reactions for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions  for the students and aspirants of Chemistry12th.pptxOrganic Name Reactions  for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions for the students and aspirants of Chemistry12th.pptx
 
Staff of Color (SOC) Retention Efforts DDSD
Staff of Color (SOC) Retention Efforts DDSDStaff of Color (SOC) Retention Efforts DDSD
Staff of Color (SOC) Retention Efforts DDSD
 

Insuficiencia suprarrenal 2018

  • 1. Insuficiencia suprarrenal Hospital General “Dr. Nicolás San Juan” Servicio de Medicina Interna Daniel Rebolledo García R3 Medicina Interna Diciembre 2018 Toluca, México
  • 2. • Descrita por Thomas Addison en 1855. (Debilidad, fatiga, anorexia, hipotensión ortostatica, ingesta de sal). • La causa mas frecuente en los casos descritos fue la tuberculosis (siglo XIX). Curr Opin Endocrinol Diabetes Obes. 2010 June ; 17(3): 217-223
  • 3.
  • 4. Definición • Es la falla de producción de todas las hormonas de la corteza suprarrenal. • La causa más frecuente en países desarrollados es la autoinmune. • Puede ocurrir de forma aislada, con otros cuadros autoinmunes (síndrome poliglandular tipo 1 y 2). • Mutaciones ligadas al gen AIRE. • HLA genotipo DR3/4-DQB1*0302 (diabetes mellitus tipo 1). • Adrenoleucodistrofia ligada al X.
  • 5. Epidemiología • Addison’s disease has a prevalence of 93-140 per million people and an annual incidence of 4.7-6.2 per million people in Western populations. • A survey of patients with Addison’s disease found that 60% had seen two or more clinicians before the diagnosis of Addison’s disease was ever considered. • An observational study of children with Addison’s disease found that a delay in diagnosis occurred in about a third of the cases, in whom the median duration between the onset of first symptoms and the correct diagnosis was two years.
  • 6. • Before the availability of synthetic glucocorticoid replacement therapy, the disease resulted in a 2-year mortality above 80% and the death of all patients within 5 years of diagnosis.
  • 7.
  • 9. Am Fam Physician. 2014;89(7):563-568
  • 12.
  • 14. Am Fam Physician. 2014;89(7):563-568
  • 15.
  • 16. Am Fam Physician. 2014;89(7):563-568
  • 17. Am Fam Physician. 2014;89(7):563-568
  • 19.
  • 20. The American Journal of Medicine (2016) 129, 339.e1-339.e9
  • 21. The American Journal of Medicine (2016) 129, 339.e1-339.e9
  • 22. The American Journal of Medicine (2016) 129, 339.e1-339.e9
  • 23. Manejo en urgencias… • In patients in adrenal crisis after hospital admission, if acute adrenal insufficiency is clinically suspected. • Hydrocortisone should be given without delay (100 mg bolus injection, followed by 200 mg per 24 h either as a continuous infusion or 50 mg every 6 h). • Along with intravenous fluid resuscitation.
  • 24. • Intravenous fluid resuscitation with isotonic sodium chloride 0.9% will correct the hypovolemia and hyponatremia, while intravenous dextrose may also be required to correct hypoglycemia.
  • 25. • One liter of saline 0.9% should be given over the first hour, and further replacement fluids should be guided by frequent hemodynamic monitoring and measurement of serum electrolytes.
  • 26. • Cortisol replacement can induce water diuresis and suppress antidiuretic hormone (in secondary adrenal insufficiency), which together with sodium replacement can lead to rapid correction of hyponatremia, and osmotic demyelination syndrome.
  • 27. • In the hospital, hydrocortisone can be given intravenously or intramuscularly 100 mg as a bolus, followed by 100-300 mg per day for another 2 to 3 days, either as boluses every 6 hours or as continuous infusion until full recovery.
  • 28. • At hydrocortisone doses of >50 mg/day, there is sufficient action at the mineralocorticoid receptor, and it is generally accepted that additional mineralocorticoid therapy is not required.
  • 29. The American Journal of Medicine (2016) 129, 339.e1-339.e9
  • 30. The American Journal of Medicine (2016) 129, 339.e1-339.e9
  • 31. • Daily physiological production of cortisol is about 5–6 mg/m2 body surface area. • Recommended hydrocortisone doses are 15–25 mg, usually given in two to three doses per day, with 50–66% given in the morning on awakening. • If given two times a day, the second dose is usually given 6–8 h after the morning dose. • If given three times per day, the second dose is given 4–6 h after the early morning dose and the third dose 4–6 h after this.
  • 32. • A global survey of more than 1000 patients, mostly with primary adrenal insufficiency. • Hydrocortisone was the most common treatment (75%), • Prednisone or prednisolone (11%), • Cortisone (6%), and dexamethasone (4%).
  • 33. • Cortisone (1 mg hydrocortisone= 1.6 mg cortisone acetate) • Prednisone • (1.0 mg hydrocortisone=0.25 mg prednisone) need intrahepatic activation to cortisol and prednisolone (1.0 mg hydrocortisone=0.2 mg prednisolone), respectively, by 11β-hydroxy steroid dehydrogenase type 1, which might lead to a higher pharmacokinetic variability compared with hydrocortisone.
  • 34. Am Fam Physician. 2014;89(7):563-568
  • 35.
  • 36.